WGS$64.097.20%-4.97
Genedx Holdings Corp (WGS)
Date: 2026-11-02 16:00O: 69.15H: 69.53L: 63.61C: 64.09Vol: 1.150M
Genedx Holdings Corp stock is traded at $64.09, with a volume of 1,149,768. It is down -7.20% in the last 24 hours and down -12.31% over the past month. GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
Previous Close:
$69.06
Open:
$69.15
24h Volume:
1,149,768
Relative Volume:
1.14
Market Cap:
$1.91B
Revenue:
$442.68M
Net Income/Loss:
-$77.81M
P/E Ratio:
-
EPS:
-$2.67
Net Cash Flow:
-$28.65M
1W Performance:
+2.15%
1M Performance:
-12.31%
6M Performance:
-1.97%
1Y Performance:
-53.66%
1-Day Range:
$0.00$0.00
1-Week Range:
$63.19$71.50
52-Week Range:
$32.21$170.87
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings CorpSector
HealthcareIndustry
Diagnostics & ResearchPhone
888-729-1206Address
333 LUDLOW STREET, STAMFORD, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
Genedx Holdings Corp Stock (WGS) Financials Data
Genedx Holdings Corp Stock (WGS) Insider Trading
- Fuchs ThomasSep 17 '26Director
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 1,146
- Value ($)
- 0
- #Shares Total
- 1,146
- Stueland KatherineSep 16 '26CHIEF EXECUTIVE OFFICER
- Transaction
- Sale
- Cost
- $97.61
- #Shares
- 10,501
- Value ($)
- 1,025,013
- #Shares Total
- 115,476
- Feeley KevinSep 16 '26CHIEF FINANCIAL OFFICER
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 7,197
- Value ($)
- 0
- #Shares Total
- 48,673
- Stueland KatherineSep 16 '26CHIEF EXECUTIVE OFFICER
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 18,750
- Value ($)
- 0
- #Shares Total
- 125,977
- Feeley KevinSep 16 '26CHIEF FINANCIAL OFFICER
- Transaction
- Sale
- Cost
- $97.61
- #Shares
- 3,728
- Value ($)
- 363,892
- #Shares Total
- 44,945
- Feeley KevinSep 09 '26CHIEF FINANCIAL OFFICER
- Transaction
- Sale
- Cost
- $84.22
- #Shares
- 1,285
- Value ($)
- 108,220
- #Shares Total
- 41,476
- Feeley KevinSep 09 '26CHIEF FINANCIAL OFFICER
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 2,462
- Value ($)
- 0
- #Shares Total
- 42,761
- Stueland KatherineSep 09 '26CHIEF EXECUTIVE OFFICER
- Transaction
- Sale
- Cost
- $84.22
- #Shares
- 3,692
- Value ($)
- 310,932
- #Shares Total
- 107,227
- Stueland KatherineSep 09 '26CHIEF EXECUTIVE OFFICER
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 6,547
- Value ($)
- 0
- #Shares Total
- 110,919
- Katherine StuelandSep 09 '26Officer
- Transaction
- Proposed Sale
- Cost
- $84.82
- #Shares
- 14,243
- Value ($)
- 1,208,100
- #Shares Total
- 0
